EUVIMEDEUVIMED entdecken
Crossref

DeepMoDRP: A Multi‐Omics‐Based Deep Learning Framework for Drug Response Prediction in Brain Cancer

Yuxuan Li, Xiumin Shi iD, Lu Wang iD, Lianzhong Zhang iD

Molecular Informatics · 2026

DOI: 10.1002/minf.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Informatics, 2026. Verfasst von Yuxuan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Information and Electronics, Beijing Institute of Technology, Beijing, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Deep Learning, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Considering the limited efficacy of existing pharmacotherapies for brain tumors, the development of accurate predictive models is essential for advancing neuro‐oncology treatment strategies. In this article, we introduce a drug response prediction model, DeepMoDRP, specifically designed for brain cancer. This model integrates genomic, transcriptomic, and epigenomic data from various brain tumor cell lines, including low‐grade glioma, glioblastoma multiforme, and diffuse large B‐cell lymphoma. To address the high‐dimensional complexity inherent in gene expression and copy number variations within cell line data, we have integrated sparse autoencoders (AEs) and denoising AEs to reduce noise and redundancy. Meanwhile, one‐dimensional convolutional neural networks are utilized to process the low‐dimensional mutation and DNA methylation data. Additionally, a multiscale graph neural network is implemented to handle the drug‐related data. Finally, fully connected networks are employed to generate predictions of drug responses. A series of experiments were conducted utilizing a brain tumor dataset that was extracted and curated from public databases. The experimental results demonstrate that the proposed DeepMoDRP outperforms the performance of state‐of‐the‐art pan‐cancer baseline models in predicting drug responses for brain tumors. The downstream analysis indicates that the DeepMoDRP holds significant promise for the treatment of brain tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsDeep LearningAntineoplastic AgentsHumansMultiomicsAutoencoderGraph Neural NetworksCell Line, TumorConvolutional Neural Networks

Stichwörter der Autor:innen

brain cancerdenoising autoencoderdrug response predictiongraph neural networkmuti‐omics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Information and Electronics, Beijing Institute of Technology, Beijing, China.
  • Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Xiumin Shi, Lu Wang, Lianzhong Zhang

Zitieren

APA

Li, Y., Shi, X., Wang, L., & Zhang, L. (2026). DeepMoDRP: A Multi‐Omics‐Based Deep Learning Framework for Drug Response Prediction in Brain Cancer. Molecular Informatics. https://doi.org/10.1002/minf.70020

Vancouver

Li Y, Shi X, Wang L, Zhang L. DeepMoDRP: A Multi‐Omics‐Based Deep Learning Framework for Drug Response Prediction in Brain Cancer. Molecular Informatics. 2026. doi:10.1002/minf.70020

BibTeX
@article{Li2026,
  author = {Li, Yuxuan and Shi, Xiumin and Wang, Lu and Zhang, Lianzhong},
  title = {DeepMoDRP: A Multi‐Omics‐Based Deep Learning Framework for Drug Response Prediction in Brain Cancer},
  journal = {Molecular Informatics},
  year = {2026},
  doi = {10.1002/minf.70020}
}
Kostenlos starten →